SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. V. Marangon, R. A. Moliterno, A. M. Sell, C. F. V. de Moraes, R. M. T. Grotto, M. C. Pardini, D. S. De Pauli, J. E. L. Visentainer, G. F. Silva, Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C, International Journal of Immunogenetics, 2012, 39, 3
  2. 2
    Kyong-Mi Chang, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  3. 3
    B. S. de Almeida, G. M. Fabrício Silva, P. M. da Silva, R. de Mello Perez, F. A. F. Figueiredo, L. C. Porto, Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population, Journal of Viral Hepatitis, 2011, 18, 10
  4. 4
    L. O. F. Cangussu, R. Teixeira, E. F. Campos, G. F. Rampim, S. A. Mingoti, O. A. Martins-Filho, M. Gerbase-DeLima, HLA Class II Alleles and Chronic Hepatitis C Virus Infection, Scandinavian Journal of Immunology, 2011, 74, 3
  5. 5
    Julia Schmidt, Robert Thimme, Christoph Neumann-Haefelin, Host genetics in immune-mediated hepatitis C virus clearance, Biomarkers in Medicine, 2011, 5, 2, 155

    CrossRef

  6. 6
    Taku Miyasaka, Shin-nosuke Takeshima, Yuki Matsumoto, Naohiko Kobayashi, Tamako Matsuhashi, Yoshiyuki Miyazaki, Yoshihiro Tanabe, Kazuki Ishibashi, Hiroshi Sentsui, Yoko Aida, The diversity of bovine MHC class II DRB3 and DQA1 alleles in different herds of Japanese Black and Holstein cattle in Japan, Gene, 2011, 472, 1-2, 42

    CrossRef

  7. 7
    Y. M. Mosaad, R. E. Farag, M. M. Arafa, S. Eletreby, H. A. El-Alfy, B. S. Eldeek, Z. M. Tawhid, Association of Human Leucocyte Antigen Class I (HLA-A and HLA-B) With Chronic Hepatitis C Virus Infection in Egyptian Patients, Scandinavian Journal of Immunology, 2010, 72, 6
  8. 8
    Eric R. Kallwitz, Jennifer Layden–Almer, Manish Dhamija, Jamie Berkes, Grace Guzman, Rita Lepe, Scott J. Cotler, Thomas J. Layden, Ethnicity and Body Mass Index Are Associated With Hepatitis C Presentation and Progression, Clinical Gastroenterology and Hepatology, 2010, 8, 1, 72

    CrossRef

  9. 9
    V. De Re, L. Caggiari, G. Monti, M. Libra, M. Spina, R. Dolcetti, M. De Zorzi, V. Racanelli, M. Crovatto, G. Toffoli, HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia, Tissue Antigens, 2010, 75, 2
  10. 10
    Thomas Sersté, Marcel Nkuize, Rami Moucari, Marc Van Gossum, Marijke Reynders, Robert Scheen, Françoise Vertongen, Michel Buset, Jean Pierre Mulkay, Patrick Marcellin, Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity, Liver International, 2010, 30, 8
  11. 11
    Mark H. Kuniholm, Andrea Kovacs, Xiaojiang Gao, Xiaonan Xue, Darlene Marti, Chloe L. Thio, Marion G. Peters, Norah A. Terrault, Ruth M. Greenblatt, James J. Goedert, Mardge H. Cohen, Howard Minkoff, Stephen J. Gange, Kathryn Anastos, Melissa Fazzari, Tiffany G. Harris, Mary A. Young, Howard D. Strickler, Mary Carrington, Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia, Hepatology, 2010, 51, 5
  12. 12
    Arthur Y. Kim, Raymond T. Chung, Coinfection With HIV-1 and HCV—A One-Two Punch, Gastroenterology, 2009, 137, 3, 795

    CrossRef

  13. 13
    Andri Rauch, Silvana Gaudieri, Chloe Thio, Pierre-Yves Bochud, Host genetic determinants of spontaneous hepatitis C clearance, Pharmacogenomics, 2009, 10, 11, 1819

    CrossRef